Clinical trial
The Role of microRNA-210 in Regulating Oxidative Stress in Patients With Peripheral Artery Disease
NCT04089943 is registered in ClinicalTrials.gov with University of West Florida as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of microRNA-210 in Regulating Oxidative Stress in Patients With Peripheral Artery Disease
- Lead sponsor
- University of West Florida
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 15, 2019
- Completion date
- August 25, 2025
- Enrollment
- 230 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
arterial occlusive diseases, atherosclerosis, peripheral arterial disease, vascular diseases, peripheral